High day-to-day glucose variability: A frequent phenomenon in children and adolescents with type 1 diabetes attending summer camp

Diabetes and Metabolism

Volumn 34, Issue 1, 2008, Pages 46-51

  Choleau, C ^a   Aubert, C ^b   Cahane M ^b   Reach, G ^a  

^a AVICENNE HOSPITAL   (France)

^b Aide aux jeunes diabétiques ^*  (France)

Author keywords

CGM; Day to day variability; Insulin adjustment; MODD

Indexed keywords

GLUCOSE; INSULIN DERIVATIVE; INSULIN GLARGINE;

ARTICLE; BLOOD GLUCOSE MONITORING; CAMPING; CHILD; CLINICAL ARTICLE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; JUVENILE DIABETES MELLITUS;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; BLOOD GLUCOSE; CAMPING; CHILD; DIABETES MELLITUS, TYPE 1; HUMANS;

EID: 39149134308     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2007.12.002     Document Type: Article

References (28)

1. Service F.J., Molnar G.D., Rosevear J.W., Ackerman E., Gatewood L.C., and Taylor W.F. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19 (1970) 644-655
2. Molnar G.D., Taylor W.F., and Ho M.M. Day-to-day glucose variation of continuously glycaemia: a further measure of diabetic instability. Diabetologia 8 (1972) 342-348
3. Guerci B. Asymptomatic glycemic instability: how to measure it and which clinical applications. Review. Diabetes Metab 29 (2003) 179-188
4. Binder C., Lauritzen T., Faber O., and Pramming S. Insulin pharmacokinetics. Review. Diabetes Care 7 (1984) 188-199
5. Bolli G.B. Physiological insulin replacement in type 1 diabetes mellitus. Exp Clin Endocrinol diabetes 109 Suppl. 2 (2001) S317-S332
6. Alemzadeh R., Loppnow C., Parton E., and Kirby M. Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diabetes Technol Ther 5 (2003) 167-173
7. Thow J.C., Johnson A.B., Marsden S., Taylor R., and Home P.D. Morphology of palpably abnormal injection sites and effects on absorption of isophane (NPH) insulin. Diabet Med 7 (1990) 795-799
8. Lepore M., Bartocci L., Fanelli C., Pampanelli F., Porcellati F., and Bolli G.B. Effect of adequate vs inadequate resuspension of NPH insulin prior to s.c. injection on pharmacokinetics and dinamics in T1 DM. Diabetologia 44 (2001) A25 [Abstract]
9. Irvine A.A., Cox D., and Gonder-Frederick L. Fear of hypoglycemia: relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus. Health Psychol 11 (1992) 135-138
10. Thompson C.J., Cummings J.F., Chalmers J., Gould C., and Newton R.W. How have patients reacted to the implications of the DCCT?. Diabetes Care 19 (1996) 876-879
11. Pickup J.C., Kidd J., Burmiston S., and Yemane N. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev 22 (2006) 232-237
12. Aussedat B., Dupire-Angel M., Giffort R., Klein J.C., Wilson G.S., and Reach G. Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. Am J Physiol Endocrinol Metab 278 (2000) E716-E728
13. Choleau C., Klein J.C., Reach G., Aussedat B., Demaria-Pesce V., Wilson G.S., et al. Calibration of a subcutaneous amperometric glucose sensor implanted for 7 days in diabetic patients. Part 2: superiority of the one-point calibration method. Biosens Bioelectron 17 (2002) 647-654
14. Grimm J.J., Berger W., and Ruiz J. Functional insulin therapy: patient education and algorithms. Diabetes Metab 28 (2002) 2S15-2S18
15. Bode B.W., Gross T.M., Thornton K.R., and Mastrototaro J.J. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 46 (1999) 183-190
16. Kaufman F.R., Gibson L.C., Halvorson M., Carpenter S., Fisher L.K., and Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 24 (2001) 2030-2034
17. Schaepelynck-Belicar P., Vague P., Simonin G., and Lassemann-Vague V. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). Diabetes Metab 29 (2003) 608-612
18. Salardi S., Zucchini S., Santoni R., Ragni L., Gualandi S., Cicognani A., et al. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients. Diabetes Care 25 (2002) 1840-1844
19. Chase H.P., Kim L.M., Owen S.L., MacKenzie T.A., Klingensmith G.J., Murtfeldt R., et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 107 (2001) 222-226
20. Chico A., Vidal-Rios P., Subira M., and Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 26 (2003) 1153-1157
21. Tanenberg R., Bode B., Lane W., Levetan C., Mestman J., Harmel A.P., et al. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc 79 (2004) 1521-1526
22. Yates K., Milton A.H., Dear K., and Ambler G. Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial. Diabetes Care 29 (2006) 1512-1517
23. Lagarde W.H., Barrows F.P., Davenport M.L., Kang M., Guess H.A., and Calikoglu A.S. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes 7 (2006) 159-164
24. Ludvigsson J., and Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 111 (2003) 933-938
25. Chase H.P., Dixon B., Pearson J., Fiallo-Scharer R., Walravens P., Klingensmith G., et al. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin. J Pediatr 143 (2003) 737-740
26. Chase H.P., Beck R., Tamborlane W., Buckingham B., Mauras N., Tsalikian E., et al. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 28 (2005) 1101-1106
27. Deiss D., Hartmann R., Schmidt J., and Kordonouri O. Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes 114 (2006) 63-67
28. Kerssen A., de Valk H.W., and Visser G.H. Day-to-day variability during pregnancy in women with type 1 diabetes mellitus: glucose profiles measured with the Continuous Glucose Monitoring. BJOG 111 (2004) 919-924